Growing at an annualized rate of 10%, the fragment-based drug discovery market / ByRoots Analysis

Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges<br><br>London<br><br>Roots Analysis has announced the addition of the u201cFragment-based Drug Discovery Market: Library and Service Providers, 2020-2030u201d report to its list of offerings. <br><br>According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable pharmacological leads against otherwise hard to target biomolecules. In fact, many service provider companies are offering fragment libraries and support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.<br> <br>To order this 170 page report, which features 55 figures and 80 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html<br><br>Contact:<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br> 44 (122) 391 1091<br>Gaurav.Chaudhary@rootsanalysis.com<br><br><br>

kevin987 + Follow